Literature DB >> 10484604

Differential binding of proteins to peroxisomes in rat hepatoma cells: unique association of enzymes involved in isoprenoid metabolism.

S D Gupta1, R S Mehan, T R Tansey, H T Chen, G Goping, I Goldberg, I Shechter.   

Abstract

Farnesyl diphosphate synthase (FPPS: EC2.5.1.10), a key enzyme in isoprenoid metabolic pathways, catalyzes the synthesis of farnesyl diphosphate (FPP) an intermediate in the biosynthesis of both sterol and non-sterol isoprenoid end products. The localization of FPPS to peroxisomes has been reported (Krisans, S. K., J. Ericsson, P. A. Edwards, and G. A. Keller. 1994. J. Biol. Chem. 269: 14165;-14169). Using indirect immunofluorescence and immunoelectron microscopic techniques we show here that FPPS is localized predominantly in the peroxisomes of rat hepatoma H35 cells. However, the partial release of 60;-70% of cellular FPPS activity is observed by selective permeabilization of these cells with digitonin. Under these conditions, lactate dehydrogenase, a cytosolic enzyme, is completely released whereas catalase, a known peroxisomal enzyme, is fully retained. Digitonin treatment of H35 cells differentially affects the release of other peroxisomal enzymes involved in isoprenoid metabolism. For instance, mevalonate kinase and phosphomevalonate kinase are almost totally released (95% and 91%, respectively), whereas 3-hydroxy-3-methylglutaryl-CoA reductase is fully retained. Indirect immunoflourescence studies indicate that FPPS is localized in peroxisomes of Chinese hamster ovary (CHO)-K1 cells but is dispersed in the cytosol of ZR-82 cells, a mutant that lacks peroxisomes. Unlike in H35 cells, FPPS is completely released upon digitonin permeabilization of CHO-K1 and ZR-82 cells. In contrast, under the same permeabilization conditions, catalase is fully retained in CHO-K1 cells but completely released from ZR-82 cells. These studies indicate that FPPS and other enzymes in the isoprenoid biosynthetic pathways, involved in the formation of FPP, are differentially associated with peroxisomes and may easily diffuse to the cytosol. Based on these observations, the significance and a possible regulatory model in the formation of isoprenoid end-products are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484604

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Subcellular localization of Arabidopsis 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Authors:  Pablo Leivar; Víctor M González; Susanna Castel; Richard N Trelease; Carmen López-Iglesias; Montserrat Arró; Albert Boronat; Narciso Campos; Albert Ferrer; Xavier Fernàndez-Busquets
Journal:  Plant Physiol       Date:  2004-12-23       Impact factor: 8.340

2.  Localization of the pre-squalene segment of the isoprenoid biosynthetic pathway in mammalian peroxisomes.

Authors:  Werner J Kovacs; Khanichi N Tape; Janis E Shackelford; Xueying Duan; Takhar Kasumov; Joanne K Kelleher; Henri Brunengraber; Skaidrite K Krisans
Journal:  Histochem Cell Biol       Date:  2006-12-19       Impact factor: 4.304

3.  Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate synthetase.

Authors:  Laurent Lefèbvre; Alain Vanderplasschen; Vincenzo Ciminale; Hubertine Heremans; Olivier Dangoisse; Jean-Claude Jauniaux; Jean-François Toussaint; Vlado Zelnik; Arsène Burny; Richard Kettmann; Luc Willems
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  A novel role for farnesyl pyrophosphate synthase in fibroblast growth factor-mediated signal transduction.

Authors:  John F Reilly; Shawndra D Martinez; Gregory Mickey; Pamela A Maher
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

5.  Molecular Cloning and Functional Analysis of DXS and FPS Genes from Zanthoxylum bungeanum Maxim.

Authors:  Lu Tian; Jingwei Shi; Lin Yang; Anzhi Wei
Journal:  Foods       Date:  2022-06-14

6.  Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model.

Authors:  Werner J Kovacs; Janis E Shackelford; Khanichi N Tape; Michael J Richards; Phyllis L Faust; Steven J Fliesler; Skaidrite K Krisans
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Hepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acids.

Authors:  Catherine Le Jossic-Corcos; Céline Gonthier; Isabelle Zaghini; Emmanuelle Logette; Ishaiahu Shechter; Paulette Bournot
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

8.  Dietary-suppression of hepatic lipogenic enzyme expression in intact male transgenic mice.

Authors:  Maria Notarnicola; Maria Gabriella Caruso; Angela Tafaro; Valeria Tutino; Giusy Bianco; Mario Minoia; Antonio Francavilla
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

9.  Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.

Authors:  S Blondel; A-L Egesipe; P Picardi; A-L Jaskowiak; M Notarnicola; J Ragot; J Tournois; A Le Corf; B Brinon; P Poydenot; P Georges; C Navarro; P R Pitrez; L Ferreira; G Bollot; C Bauvais; D Laustriat; A Mejat; A De Sandre-Giovannoli; N Levy; M Bifulco; M Peschanski; X Nissan
Journal:  Cell Death Dis       Date:  2016-02-18       Impact factor: 8.469

10.  Farnesyl diphosphate synthase, the target for nitrogen-containing bisphosphonate drugs, is a peroxisomal enzyme in the model system Dictyostelium discoideum.

Authors:  James M Nuttall; Ewald H Hettema; Donald J Watts
Journal:  Biochem J       Date:  2012-11-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.